0001921094-23-000485.txt : 20230814
0001921094-23-000485.hdr.sgml : 20230814
20230814144439
ACCESSION NUMBER: 0001921094-23-000485
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 231168805
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ho Carole
CENTRAL INDEX KEY: 0001724605
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O DENALI THERAPEUTICS INC.
STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
144
1
primary_doc.xml
144
0001724605
XXXXXXXX
LIVE
0001714899
Denali Therapeutics Inc.
001-38311
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
(650) 866-8548
Ho Carole
Officer
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
2768
65850.00
137422131
08/14/2023
NASDAQ
Common
08/09/2023
Restricted Stock Lapse
Denali Therapeutics Inc.
N
2768
08/09/2023
Equity Compensation
N
Carole Ho
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
Denali Therapeutics Inc.
08/10/2023
2857
68983.00
Shares sold in ROHATGI-HO FAMILY 2009 REVOCABLE TRUST.
08/14/2023
03/30/2023
Carole Ho TTEE